COMBINATION, ITS APPLICATION AND METHODS FOR TREATMENT USING SPECIFIED COMBINATION Russian patent published in 2021 - IPC A61K31/505 A61K31/5395 A61K47/12 A61K47/26 A61K47/32 A61K47/36 A61K47/38 A61P31/18 

FIELD: medicine; pharmaceutics.

SUBSTANCE: group of inventions relates to the field of medicine and pharmaceutics, namely to a two-layer tablet for the treatment of HIV infection, where the first layer contains (in mg): intragranular ingredients: sodium dolutegravir - 52.62, D-mannitol - 145.38, microcrystal cellulose - 60.00, povidone K29/32 - 15.00, sodium starch glycolate - 15.00, purified water - q.s.; extragranular ingredients: sodium starch glycolate - 6.00, sodium stearyl fumarate - 6.00; and the second layer contains (in mg): rilpivirine hydrochloride - 27.50, lactose monohydrate - 55.145, sodium croscarmellose - 1.10, povidone K30 - 3.25, polysorbate 20 - 0.35, purified water - q.s., D-mannitol - 57.755, silicated microcrystal cellulose - 40.00, sodium starch glycolate - 12.90, magnesium stearate - 2.00; and also to a method for the treatment of HIV infection including the injection of the specified tablet to a patient.

EFFECT: group of inventions provides increased stability of active components by preventing the disproportion of their salt forms.

2 cl, 16 dwg, 24 tbl, 8 ex